Analyst Evan Seigerman of BMO Capital maintained a Hold rating on Bristol-Myers Squibb (BMY – Research Report), retaining the price target of $61.00. Pick the best stocks and maximize your ...

First, though, June Squibb will have to invite you in, because the table is at the entrance to her kitchen, next to a formidable glassed-in bookcase that sports an impressive collection of ...

Bristol-Myers Squibb can probably continue to grow for a long time. Its dividend looks to be sustainable at the moment. But its debt load is a concern. But solid companies don't always make for ...

2024--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) announced results from 18 presentations reinforcing its leadership in cell therapy, with data demonstrating efficacy, durability and safety ...

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has declared a quarterly dividend of sixty-two cents ($0.62) per share on the $0.10 ...

Bristol-Myers Squibb (NYSE: BMY) is the kind of stock that potentially has a lot to offer to investors looking for wealth-building investments. With a large repertoire of medicines on the market ...

Acadia Pharmaceuticals has hired Big Pharma veteran Thomas Andrew Garner as its new chief commercial officer (CCO). The company is looking to consolidate its older drug, Nuplazid, while boosting ...

Another wave of layoffs is set to impact New Jersey’s pharmaceutical sector. Novartis and Bristol Myers Squibb both recently disclosed planned workforce reductions. In a filing with the state ...

In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against the other stocks that are close to becoming dividend aristocrats. Income investors are ...

Which ice hockey sticks are best? Lace up the skates and drop the puck. Ice hockey is a popular sport in North America. Having the right hockey stick can make a big difference in controlling the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...